| scholarly article | Q13442814 |
| P2093 | author name string | Gislaine T Rezin | |
| Jucélia J Fortunato | |||
| Aline Gassenferth | |||
| Aline H Mello | |||
| Luana R Souza | |||
| P2860 | cites work | Nutritional therapies for mental disorders | Q21245899 |
| Emerging targets for antidepressant therapies | Q28247614 | ||
| Omega-3 fatty acids for the prevention of postpartum depression: negative data from a preliminary, open-label pilot study | Q30907762 | ||
| Glutathione depletion, lipid peroxidation and mitochondrial dysfunction are induced by chronic stress in rat brain | Q31969991 | ||
| Fish consumption and omega-3 polyunsaturated fatty acids in relation to depressive episodes: a cross-sectional analysis | Q33580185 | ||
| Glycerophospholipids in brain: their metabolism, incorporation into membranes, functions, and involvement in neurological disorders | Q33908027 | ||
| Efficiency of conversion of alpha-linolenic acid to long chain n-3 fatty acids in man. | Q33957410 | ||
| Omega-3 fatty acids in psychiatry | Q33984834 | ||
| High levels of depressive symptoms in pregnancy with low omega-3 fatty acid intake from fish | Q34016602 | ||
| Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder | Q34116387 | ||
| Agomelatine, the first melatonergic antidepressant: discovery, characterization and development | Q34122643 | ||
| Omega-3 fatty acids in inflammation and autoimmune diseases | Q34164525 | ||
| Essential fatty acids and the brain | Q34194497 | ||
| Age-related changes of n-3 and n-6 polyunsaturated fatty acids in the anterior cingulate cortex of individuals with major depressive disorder | Q34201567 | ||
| Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial. | Q34218148 | ||
| Nutrition and depression: implications for improving mental health among childbearing-aged women | Q34436373 | ||
| The influence of a maternal diet rich in linoleic acid on brain and retinal docosahexaenoic acid in the rat. | Q48692768 | ||
| Fish consumption and severely depressed mood, findings from the first national nutrition follow-up study. | Q48859579 | ||
| The effect of low-dose omega 3 fatty acids on the treatment of mild to moderate depression in the elderly: a double-blind, randomized, placebo-controlled study. | Q48911413 | ||
| alpha-Linolenic acid dietary deficiency alters age-related changes of dopaminergic and serotoninergic neurotransmission in the rat frontal cortex. | Q49043298 | ||
| Lowered serum n-3 polyunsaturated fatty acid (PUFA) levels predict the occurrence of postpartum depression: further evidence that lowered n-PUFAs are related to major depression. | Q49152308 | ||
| Randomised double-blind placebo-controlled trial of fish oil in the treatment of depression. | Q50981032 | ||
| Randomized dose-ranging pilot trial of omega-3 fatty acids for postpartum depression. | Q51922714 | ||
| Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. | Q51984734 | ||
| Omega-3 treatment of childhood depression: a controlled, double-blind pilot study. | Q55042041 | ||
| Major Depressive Disorder | Q56016676 | ||
| Fatty acid composition in major depression: decreased ω3 fractions in cholesteryl esters and increased C20:4ω6C20:5ω3 ratio in cholesteryl esters and phospholipids | Q56767442 | ||
| The monocyte-T-lymphocyte hypothesis of major depression | Q56767511 | ||
| Omega-3 Treatment of Childhood Depression: A Controlled, Double-Blind Pilot Study | Q56816526 | ||
| Plasma fatty acid composition and depression are associated in the elderly: the Rotterdam Study | Q57338021 | ||
| Changes in the fatty acid patterns of brain phospholipids during development of rats fed peanut or rapeseed oil, taking into account differences between milk and maternal food | Q71757923 | ||
| A Double-Blind, Placebo-Controlled Study of the Omega-3 Fatty Acid Docosahexaenoic Acid in the Treatment of Major Depression | Q73343980 | ||
| Fish consumption, depression, and suicidality in a general population | Q73852106 | ||
| Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients | Q74349181 | ||
| Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients | Q74446175 | ||
| Depression and cardiovascular mortality: a role for n-3 fatty acids? | Q79422085 | ||
| Omega-3 polyunsaturated fatty acids and depression: a review of the evidence and a methodological critique | Q34563176 | ||
| Selective deficits in the omega-3 fatty acid docosahexaenoic acid in the postmortem orbitofrontal cortex of patients with major depressive disorder | Q34594598 | ||
| No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomised controlled trial | Q34705796 | ||
| Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy | Q34720379 | ||
| Functional interaction between 5-HT(6) receptors and hypothalamic-pituitary-adrenal axis: cognitive implications. | Q34738300 | ||
| Omega-3 fatty acids in mood disorders: an overview | Q35219690 | ||
| Glutamate as a therapeutic target in psychiatric disorders | Q35847653 | ||
| Omega-3 fatty acid augmentation of citalopram treatment for patients with major depressive disorder. | Q36034152 | ||
| Hypercortisolemia and depression. | Q36161754 | ||
| Review of the literature on major mental disorders in adult patients with mitochondrial diseases | Q36356446 | ||
| Gendered dimensions of obesity in childhood and adolescence | Q36492434 | ||
| Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: an overview. | Q36579978 | ||
| The mitochondrial energy transduction system and the aging process | Q36614262 | ||
| Supramolecular structure of the mitochondrial oxidative phosphorylation system | Q36652816 | ||
| Endophenotypes in the genetic analyses of mental disorders. | Q36917780 | ||
| Deficiency of essential fatty acids and membrane fluidity during pregnancy and lactation | Q37524407 | ||
| Omega-3 fatty acids in major depressive disorder | Q37631816 | ||
| Complementary and alternative medicine for the treatment of depressive disorders in women | Q37729489 | ||
| Prevalence and clinical course of depression: a review. | Q37912685 | ||
| Psychiatric syndromes linked to reproductive function in women: a review of current knowledge | Q38216735 | ||
| Role of essential fatty acids in the function of the developing nervous system | Q41053384 | ||
| Inactivation of brain mitochondrial Lon protease by peroxynitrite precedes electron transport chain dysfunction | Q42438162 | ||
| An open trial of Omega-3 fatty acids for depression in pregnancy | Q42684288 | ||
| Update and critique of natural remedies as antidepressant treatments | Q42690784 | ||
| Effect of omega-3 fatty acids supplementation on depressive symptoms and on health-related quality of life in the treatment of elderly women with depression: a double-blind, placebo-controlled, randomized clinical trial | Q42994180 | ||
| Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation. | Q43414542 | ||
| Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression: a cross-national, ecological analysis | Q43901012 | ||
| A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs | Q44169143 | ||
| Major depression is associated with lower omega-3 fatty acid levels in patients with recent acute coronary syndromes | Q44179201 | ||
| Effect of maternal docosahexaenoic acid supplementation on postpartum depression and information processing | Q44442042 | ||
| Increased risk of postpartum depressive symptoms is associated with slower normalization after pregnancy of the functional docosahexaenoic acid status | Q44541926 | ||
| Tryptophan hydroxylase-2 controls brain serotonin synthesis | Q44973406 | ||
| Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury in rats | Q45239646 | ||
| A double-blind dose-finding pilot study of docosahexaenoic acid (DHA) for major depressive disorder. | Q46552016 | ||
| The glutamatergic system and its relation to the clinical effect of therapeutic-sleep deprivation in depression - an MR spectroscopy study | Q46557124 | ||
| Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder. | Q46774006 | ||
| Fish consumption and major depression | Q47757469 | ||
| The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression | Q47965029 | ||
| n-3 polyunsaturated fatty acid deficiency and dopamine metabolism in the rat frontal cortex | Q48153654 | ||
| From homicide to happiness--a commentary on omega-3 fatty acids in human society. Cleave Award Lecture | Q48323991 | ||
| Decreased serum brain-derived neurotrophic factor levels in major depressed patients | Q48642995 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 178-185 | |
| P577 | publication date | 2014-06-01 | |
| P1433 | published in | Acta Neuropsychiatrica | Q4676734 |
| P1476 | title | ω-3 and major depression: a review | |
| P478 | volume | 26 |
| Q47569576 | DHA mediates the protective effect of fish consumption on new episodes of depression among women |
| Q40963212 | Emulsified omega-3 fatty-acids modulate the symptoms of depressive disorder in children and adolescents: a pilot study. |
| Q58554142 | Essential Role of Keap1-Nrf2 Signaling in Mood Disorders: Overview and Future Perspective |
| Q28385414 | Role of Keap1-Nrf2 signaling in depression and dietary intake of glucoraphanin confers stress resilience in mice |
| Q48040778 | Role of Omega-3 PUFAs in Neurobiological Health |
| Q61806045 | Role of Soluble Epoxide Hydrolase in Metabolism of PUFAs in Psychiatric and Neurological Disorders |
Search more.